Abbott’s FreeStyle Libre wins FDA nod

The FDA has granted Abbott Laboratories approval for its FreeStyle Libre, a wearable sensor designed to continuously monitor glucose levels in adults with diabetes without the need for finger pricks. The device, which can be worn for up to 10 days, is expected to be launched by the end of the year.